Walgreens Boots Alliance (NASDAQ:WBA) – Equities research analysts at Leerink Swann increased their Q4 2018 EPS estimates for Walgreens Boots Alliance in a research note issued to investors on Wednesday, May 23rd. Leerink Swann analyst D. Larsen now forecasts that the pharmacy operator will post earnings per share of $1.45 for the quarter, up from their previous forecast of $1.44. Leerink Swann has a “Market Perform” rating and a $70.00 price objective on the stock.
Several other equities analysts also recently weighed in on the company. ValuEngine downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Tuesday. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, May 8th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Saturday, April 7th. Jefferies Group set a $85.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, April 3rd. Finally, Scotiabank reduced their target price on Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating on the stock in a research report on Monday, April 2nd. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $82.40.
WBA opened at $63.53 on Thursday. Walgreens Boots Alliance has a 52 week low of $61.56 and a 52 week high of $83.89. The firm has a market cap of $63.38 billion, a P/E ratio of 12.46, a P/E/G ratio of 1.04 and a beta of 1.15. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.18. The business had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The business’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.36 earnings per share.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be paid a $0.40 dividend. The ex-dividend date is Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.52%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 31.37%.
In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the completion of the sale, the director now owns 13,679 shares in the company, valued at $896,795.24. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 14.80% of the stock is currently owned by company insiders.
Several hedge funds have recently bought and sold shares of WBA. State of Alaska Department of Revenue grew its stake in Walgreens Boots Alliance by 525.5% during the 4th quarter. State of Alaska Department of Revenue now owns 91,130 shares of the pharmacy operator’s stock valued at $6,615,000 after purchasing an additional 76,560 shares in the last quarter. Naples Global Advisors LLC grew its stake in Walgreens Boots Alliance by 19.8% during the 4th quarter. Naples Global Advisors LLC now owns 11,494 shares of the pharmacy operator’s stock valued at $835,000 after purchasing an additional 1,900 shares in the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO grew its stake in Walgreens Boots Alliance by 2.6% during the 4th quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 37,856 shares of the pharmacy operator’s stock valued at $2,749,000 after purchasing an additional 970 shares in the last quarter. Hendershot Investments Inc. grew its stake in Walgreens Boots Alliance by 7.8% during the 4th quarter. Hendershot Investments Inc. now owns 71,398 shares of the pharmacy operator’s stock valued at $5,185,000 after purchasing an additional 5,171 shares in the last quarter. Finally, Bowling Portfolio Management LLC grew its stake in Walgreens Boots Alliance by 26.3% during the 4th quarter. Bowling Portfolio Management LLC now owns 63,497 shares of the pharmacy operator’s stock valued at $4,611,000 after purchasing an additional 13,220 shares in the last quarter. Institutional investors and hedge funds own 60.57% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.